3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Experimental Hepatoma in 2 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, W | 1 |
| Li, X | 1 |
| Li, Z | 1 |
| Lau, CK | 1 |
| Yang, ZF | 1 |
| Lam, SP | 1 |
| Lam, CT | 1 |
| Ngai, P | 1 |
| Tam, KH | 1 |
| Poon, RT | 1 |
| Fan, ST | 1 |
2 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Experimental Hepatoma
| Article | Year |
|---|---|
Combination therapy with local radiofrequency ablation and YC-1 inhibits the proliferation and metastasis of hepatocellular carcinoma through activating β-catenin signaling.
Topics: Animals; Apoptosis; beta Catenin; Catheter Ablation; Cell Line, Tumor; Cell Movement; Cell Prolifera | 2016 |
Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma, Hepatocellular; Caspase 9; Cell | 2007 |